I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Discovery of HDAC6-Selective Inhibitor NN-390 with in Vitro..:
Nabanita Nawar (8200374)
;
Shazreh Bukhari (5693024)
;
Ashley A. Adile (6430040)
...
https://figshare.com/articles/journal_contribution/Discovery_of_HDAC6-Selective_Inhibitor_NN-390_with_i_in_Vitro_i_Efficacy_in_Group_3_Medulloblastoma/19123095. , 2022
Link:
https://doi.org/10.1021/acs.jmedchem.1c01585.s001
RT Journal T1
Discovery of HDAC6-Selective Inhibitor NN-390 with in Vitro Efficacy in Group 3 Medulloblastoma
UL https://suche.suub.uni-bremen.de/peid=base-ftsmithonian:oai:figshare.com:article_19123095&Exemplar=1&LAN=DE A1 Nabanita Nawar (8200374) A1 Shazreh Bukhari (5693024) A1 Ashley A. Adile (6430040) A1 Yujin Suk (12046710) A1 Pimyupa Manaswiyoungkul (8200386) A1 Krimo Toutah (9214896) A1 Olasunkanmi O. Olaoye (8200389) A1 Yasir S. Raouf (6430028) A1 Abootaleb Sedighi (1449262) A1 Harsimran Kaur Garcha (12046713) A1 Muhammad Murtaza Hassan (10131954) A1 William Gwynne (7858529) A1 Johan Israelian (9193629) A1 Tudor B. Radu (9214893) A1 Mulu Geletu (1343361) A1 Ayah Abdeldayem (10131951) A1 Justyna M. Gawel (6430025) A1 Aaron D. Cabral (8200392) A1 Chitra Venugopal (3416231) A1 Elvin D. de Araujo (8200395) A1 Sheila K. Singh (12046716) A1 Patrick T. Gunning (545679) YR 2022 K1 Biophysics K1 Biochemistry K1 Cell Biology K1 Genetics K1 Molecular Biology K1 Pharmacology K1 Biotechnology K1 Immunology K1 Cancer K1 Infectious Diseases K1 Biological Sciences not elsewhere classified K1 Chemical Sciences not elsewhere classified K1 anticancer effects due K1 200 – 550 K1 fold increased potency K1 cancer cell lines K1 fold therapeutic margin K1 nanomolar hdac6 potency K1 show therapeutic potential K1 robust cellular efficacy K1 selective molecules demonstrated K1 selective hdac6 inhibitor K1 group 3 mb K1 selective inhibitor nn K1 390 </ b K1 selective inhibitor K1 therapeutic potential K1 fold selectivity K1 vitro </ K1 mb ) K1 cell population K1 first hdac6 K1 therapy resistance K1 selectively targets K1 oncogenic transformation K1 leptomeningeal metastases K1 clinical studies K1 biological evaluation JF https://figshare.com/articles/journal_contribution/Discovery_of_HDAC6-Selective_Inhibitor_NN-390_with_i_in_Vitro_i_Efficacy_in_Group_3_Medulloblastoma/19123095 LK http://dx.doi.org/https://doi.org/10.1021/acs.jmedchem.1c01585.s001 DO https://doi.org/10.1021/acs.jmedchem.1c01585.s001 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)